Biogen Inc.

Biogen Inc.

251.84
USD
+70.78
(+39.09%)
2.35EPS
Feb 17Next Earn

Important Dates

Biogen Inc.'s next confirmed earnings release is scheduled for February 17, 2027.

Earnings Date2/17/2027

Share Statistics

As of September 30, 2026, Biogen Inc. has 147.75M shares outstanding.

Shares Outstanding147.75M

Financial Position

As of September 30, 2026, Biogen Inc. maintains a current ratio of 1.95, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.23, indicating elevated leverage, while an interest coverage ratio of 4.86 demonstrates adequate ability to service its debt obligations.

Current Ratio1.95
Quick Ratio0.95
Debt / Equity41.23
Debt / EBITDA5.26
Interest Coverage4.86

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Biogen Inc. posted a return on equity (ROE) of 1.87, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.81 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.13, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.27, useful for judging operating efficiency across full business cycles. The company generates approximately 1.37M in revenue per employee across its workforce of 7,500.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.21 indicates how many times Biogen Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)1.87
Return on Assets (ROA)1.13
Return on Invested Capital (ROIC)1.81
Return on Capital Employed (ROCE)2.27
Revenue Per Employee1.37M
Employee Count7,500.00
Inventory Turnover1.21

Taxes

USD

Over the twelve months ended September 30, 2026, Biogen Inc. recorded 97.60M in income tax expense. That works out to an effective tax rate of 21.93, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 445.10M, leaving 347.50M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax97.60M
Effective Tax Rate21.93

Stock Price Statistics

USD

As of the close on October 29, 2026, Biogen Inc.'s stock has gained approximately 93.37% over the past 52 weeks.

52-Week Price Change93.37%
50-Day Moving Average271.43

Income Statement

USD

Over the twelve months ended September 30, 2026, Biogen Inc. generated 10.30B in revenue and converted that into 347.50M in net income, yielding earnings per share of 2.35. EBITDA reached 1.48B, while operating income came in at 1.81B.

Revenue10.30B
Gross Profit7.62B
Operating Income1.81B
Pretax Income445.10M
Net Income347.50M
EBITDA1.48B
EBIT600.50M
Earnings Per Share (EPS)2.35

Balance Sheet

USD

As of September 30, 2026, Biogen Inc. holds 1.30B in cash and equivalents against 7.80B in total debt, resulting in a net debt position of 6.39B. Total book value stands at 18.92B, with working capital of 3.69B providing operational flexibility.

Cash & Cash Equivalents1.30B
Total Debt7.80B
Net Debt6.39B
Equity (Book Value)18.92B
Book Value Per Share128.06
Working Capital3.69B

Cash Flow

USD

Biogen Inc. produced 2.25B in operating cash flow over the twelve months ended September 30, 2026. After subtracting -602.70M in capital expenditures, free cash flow totaled 1.64B - equivalent to 11.16 per share.

Operating Cash Flow2.25B
Capital Expenditures-602.70M
Free Cash Flow1.64B
FCF Per Share11.16

Margins

Over the twelve months ended September 30, 2026, Biogen Inc. posted a gross margin of 73.96, reflecting its pricing power and cost economics. The operating margin of 17.55 and net profit margin of 3.37 provide insight into operational efficiency.

Gross Margin73.96
Operating Margin17.55
Pretax Margin4.32
Profit Margin3.37
EBITDA Margin14.40

Stock Splits

Biogen Inc.'s most recent stock split took place on January 18, 2001 with a 1:3 split ratio.

Last Split Date1/18/2001
Split Ratio1:3